Canada Spends Logo

Explorez notre analyse du budget 2026

Grant: Dissemination Events - PA: Neurosciences, Mental Health and Addiction

Direct Payment

$8,700.00

Cannabinoids and Pain Update 2012: the state of the art, the state of the science; Official Satellite Symposium of the 14th World Congress on Pain

EF 2011-12

Résumé
This event will explore up to date research on the role of cannabinoids in pain medicine. Cannabinoids are substances which affect specific cannabinoid receptors in the human body. Cannabis products have been used for medicinal purposes for centuries and there is a rapidly expanding modern field of research on the role of cannabinoids and pain and symptom management. This event is an Official Satellite Symposium of the 14th World Congress on Pain - the biannual meeting of the International Association for the Study of Pain. It builds upon the 2010 Cannabinoids and Pain: Official Satellite Symposium of the 13th World Congress on Pain held in Montreal, Canada. Pain management physicians, researchers, pharmaceutical industry and government representatives from Canada and across the globe will have a unique opportunity to disseminate and discuss recent advances in our understanding of the science of cannabinoids with respect to pain. The symposium is divided into updates on research, uses in clinical practice, and drug development. Presentations will be given by internationally renowned experts and updates on drug development will be provided in industry presentations. Ongoing research projects and young investigators will contribute via a poster presentation session. This event will conclude with a round-table discussion to reflect on the day's presentations and generate a direction for future research. This symposium will enable attendees to: 1) understand recent developments in cannabinoid neuroscience, 2) be aware of Canadian cannabinoid research initiatives, 3) appreciate actual and potential clinical applications of cannabinoids, 4) reflect on attitudes toward use of cannabinoids in clinical practice, 5) recognize areas of need for cannabinoid research and education. A White Paper will be produced based on days presentations and discussions. The symposium will also be video recorded and disseminated as an online continuing medical education activity.
Programme
Dissemination Events - PA: Neurosciences, Mental Health and Addiction
Bénéficiaire
Emplacement
—
Type
Grant
Source
CIHR Funding Decisions Database

Tel que publié

Id
245753
Name
Invest. Of Cannabinoids Can. Consortium
Region
Unknown
Country
Unknown
Orgtype
Research Institution
Instname2
Neurosciences, Mental Health and Addiction
Theme2
Not applicable / Specified
Prcname2
Dissemination Events Grants
Projecttitle
Cannabinoids and Pain Update 2012: the state of the art, the state of the science; Official Satellite Symposium of the 14th World Congress on Pain
Programtype2
Miscellaneous Programs
Orgnameinp2
Direct Payment
Cihramount2
$8,700
Cihrequipment2
$0
Programname2
Dissemination Events - PA: Neurosciences, Mental Health and Addiction
Keyworddelim
Cannabinoids; Drug Discovery; Neuroscience; Pain; Pharmaceuticals; Therapeutics
Abstract
This event will explore up to date research on the role of cannabinoids in pain medicine. Cannabinoids are substances which affect specific cannabinoid receptors in the human body. Cannabis products have been used for medicinal purposes for centuries and there is a rapidly expanding modern field of research on the role of cannabinoids and pain and symptom management. This event is an Official Satellite Symposium of the 14th World Congress on Pain - the biannual meeting of the International Association for the Study of Pain. It builds upon the 2010 Cannabinoids and Pain: Official Satellite Symposium of the 13th World Congress on Pain held in Montreal, Canada. Pain management physicians, researchers, pharmaceutical industry and government representatives from Canada and across the globe will have a unique opportunity to disseminate and discuss recent advances in our understanding of the science of cannabinoids with respect to pain. The symposium is divided into updates on research, uses in clinical practice, and drug development. Presentations will be given by internationally renowned experts and updates on drug development will be provided in industry presentations. Ongoing research projects and young investigators will contribute via a poster presentation session. This event will conclude with a round-table discussion to reflect on the day's presentations and generate a direction for future research. This symposium will enable attendees to: 1) understand recent developments in cannabinoid neuroscience, 2) be aware of Canadian cannabinoid research initiatives, 3) appreciate actual and potential clinical applications of cannabinoids, 4) reflect on attitudes toward use of cannabinoids in clinical practice, 5) recognize areas of need for cannabinoid research and education. A White Paper will be produced based on days presentations and discussions. The symposium will also be video recorded and disseminated as an online continuing medical education activity.
Competitiondate
201110
Approvedterm2
1 yr 0 mth
Pinamesdelim
Invest. Of Cannabinoids, Can. Consortium; Ware, Mark A
Approvedterm
1 an 0 mois
Cihrcontribution2
~ $8,700~ $0~